BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21216934)

  • 21. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1.
    Shen G; Xu C; Chen C; Hebbar V; Kong AN
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):317-27. PubMed ID: 16170570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
    He L; Guo S; Zhu T; Chen C; Xu K
    Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Cancer Lett; 2003 Feb; 190(2):233-43. PubMed ID: 12565178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
    Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
    Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
    Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structurally dependent redox property of ribonucleotide reductase subunit p53R2.
    Xue L; Zhou B; Liu X; Wang T; Shih J; Qi C; Heung Y; Yen Y
    Cancer Res; 2006 Feb; 66(4):1900-5. PubMed ID: 16488986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
    Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage.
    Chang L; Zhou B; Hu S; Guo R; Liu X; Jones SN; Yen Y
    Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18519-24. PubMed ID: 19015526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.
    Jiang C; Xu R; Li XX; Wang YY; Liang WQ; Zeng JD; Zhang SS; Xu XY; Yang Y; Zhang MY; Wang HY; Zheng XFS
    Cell Cycle; 2017 Sep; 16(18):1673-1682. PubMed ID: 28841361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of iron in cell cycle progression and the proliferation of neoplastic cells.
    Le NT; Richardson DR
    Biochim Biophys Acta; 2002 Oct; 1603(1):31-46. PubMed ID: 12242109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53R2 regulates thioredoxin reductase activity through interaction with TrxR2.
    Park SJ; Kim HB; Piao C; Kang MY; Park SG; Kim SW; Lee JH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):706-712. PubMed ID: 27866984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External Qi of Yan Xin Qigong inhibits activation of Akt, Erk1/2 and NF-ĸB and induces cell cycle arrest and apoptosis in colorectal cancer cells.
    Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
    Cell Physiol Biochem; 2013; 31(1):113-22. PubMed ID: 23363659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of p53R2 and its role as potential target for cancer therapy.
    Wang X; Zhenchuk A; Wiman KG; Albertioni F
    Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase.
    Pontarin G; Ferraro P; Rampazzo C; Kollberg G; Holme E; Reichard P; Bianchi V
    J Biol Chem; 2011 Apr; 286(13):11132-40. PubMed ID: 21297166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.
    Wang X; Liu X; Xue L; Zhang K; Kuo ML; Hu S; Zhou B; Ann D; Zhang S; Yen Y
    Biochem Biophys Res Commun; 2011 Jun; 410(1):102-7. PubMed ID: 21640705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.
    Ding Q; Grammer JR; Nelson MA; Guan JL; Stewart JE; Gladson CL
    J Biol Chem; 2005 Feb; 280(8):6802-15. PubMed ID: 15557280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.
    Guittet O; Håkansson P; Voevodskaya N; Fridd S; Gräslund A; Arakawa H; Nakamura Y; Thelander L
    J Biol Chem; 2001 Nov; 276(44):40647-51. PubMed ID: 11517226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
    Salabat MR; Ding XZ; Flesche JB; Ujiki MB; Robin TP; Talamonti MS; Bell RH; Adrian TE
    Pancreas; 2006 Aug; 33(2):148-55. PubMed ID: 16868480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
    Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
    Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.